Redox‐Responsive Core Cross‐Linked Micelle as Anticancer Drug Delivery Vehicle
- 16 October 2025
- journal article
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (5)
Abstract
Self‐assembled micelles are popular as a nanoplatform for cancer therapeutics. However, they still suffer from several drawbacks, like lower drug loading capacity and premature drug release. In order to overcome these issues, we have presently developed new redox‐responsive cross‐linked micelles using lipoic acid‐containing polymers, poly(NVP)‐ b ‐poly(LABPA). The self‐assembly behavior of the polymers was monitored before and after cross‐linking in the presence of a catalytic amount of glutathione (GSH). The core cross‐linked (CCL) polymeric micelles were further subjected to high GSH concentrations found in cancer cells, and the corresponding de‐cross‐linking of the core, followed by an analogous size change, was investigated using dynamic light scattering (DLS) and AFM measurements. In comparison to precursor polymers, the higher drug (doxorubicin; DOX) loading capacity (DLC) of 24.5% of the CCL micelles and GSH‐triggered rapid drug release suggested their importance as a potent drug delivery system for cancer therapy. Very often, a successful cancer treatment is inhibited by the drug resistance of the cancer cells. In this present work, the in vitro cytotoxicity study was performed using drug‐sensitive and drug‐resistant MDA‐MB‐231 cells, where a lower IC 50 value of the drug‐loaded CCL micelles was obtained in comparison to free DOX toward both drug‐sensitive and resistant cells, justifying their potential utility in cancer therapeutics. Briefly, our lipoic acid‐containing redox‐responsive polymers, poly(NVP)‐ b ‐poly(LABPA), show significantly enhanced drug loading capacity (24.5%), wonderful extracellular stability with rapid GSH‐triggered drug release in the intracellular redox environment, and importantly, the DOX‐loaded CCL micelles show significantly lower IC 50 values for both the parental and resistant cancer cells than free DOX, calling attention to their efficiency over other existing drug delivery vehicles.Keywords
Funding Information
- Anusandhan National Research Foundation (CRG/2023/006124)
This publication has 34 references indexed in Scilit:
- Redox-responsive properties of core-cross-linked micelles of poly(ethylene oxide)-b-poly(furfuryl methacrylate) for anticancer drug delivery applicationReactive and Functional Polymers, 2022
- Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential NanoprecipitationAngewandte Chemie, 2020
- Redox‐Responsive Micelles with Cores Crosslinked via Click ChemistryMacromolecular Rapid Communications, 2016
- One-pot syntheses of dual-responsive core cross-linked polymeric micelles and covalently entrapped drug by click chemistryEuropean Polymer Journal, 2016
- Core-crosslinked polymeric micelles with high doxorubicin loading capacity and intracellular pH- and redox-triggered payload releaseEuropean Polymer Journal, 2015
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targetingJournal of Controlled Release, 2010
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential AlternativesAngewandte Chemie International Edition, 2010
- Stability issues of polymeric micellesJournal of Controlled Release, 2008
- Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Improved preservation of human red blood cells by lyophilizationCryobiology, 2005